Skip Navigation

European Journal of Heart Failure 2004 6(3):327-333; doi:10.1016/j.ejheart.2004.01.006
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Galvani, M.
Right arrow Articles by Ottani, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galvani, M.
Right arrow Articles by Ottani, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 European Society of Cardiology

Natriuretic peptides for risk stratification of patients with acute coronary syndromes

Marcello Galvani*, Donatella Ferrini and Filippo Ottani

The Cardiovascular Research Unit of the Fondazione Sacco and the Department of Cardiology Ospedale G.B. Morgagni, Forlì, Italy

* Corresponding author. Present address. Fondazione Cardiologica Sacco, Piazza F.lli Ruffini, 6, 47100, Forlì, Italy. Tel.: +39-543-33283; Fax: +39-543-31720 E-mail address: galvanim{at}tin.it


   Abstract

Natriuretic peptides (BNP and NT-proBNP) have been shown to be useful tools for risk stratification of patients with acute myocardial ischemia encompassing the whole spectrum of acute coronary syndromes (ACS), particularly for prediction of mortality. Both BNP and NT-proBNP possess several characteristics of the ideal biomarker, showing independent and incremental prognostic value above traditional clinical, electrocardiographic, and biochemical (particularly troponin) risk indicators. Specifically, in ACS patients, BNP and NT-proBNP have powerful prognostic value both in patients without a history of previous heart failure or without clinical or instrumental signs of left ventricular dysfunction on admission or during hospital stay. They can also be easily and rapidly measured in an emergency context. We have performed a meta-analysis of available studies concerning the prognostic value of natriuretic peptides. Our results show that the prognostic value of natriuretic peptides is similar: (1) both at short- and long-term; (2) when natriuretic peptides are measured at first patient contact or during hospital stay; (3) for BNP or NT-proBNP; and (4) in patients with ST elevation myocardial infarction or no ST elevation ACS. These data suggest that natriuretic peptide measurement should be integrated into routine evaluation of patients with an ACS.

Key Words: Natriuretic peptide • Acute myocardial infarction • Prognosis

Received December 29, 2003; Accepted January 14, 2004


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Chem.Home page
A. Hammerer-Lercher, B. Halfinger, B. Sarg, J. Mair, B. Puschendorf, A. Griesmacher, N. A. Guzman, and H. H. Lindner
Analysis of Circulating Forms of proBNP and NT-proBNP in Patients with Severe Heart Failure
Clin. Chem., May 1, 2008; 54(5): 858 - 865.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M G Nicholls, C M Frampton, and T G Yandle
BNP: not just for heart failure
Heart, January 1, 2008; 94(1): 6 - 7.
[Full Text] [PDF]


Home page
Eur Heart JHome page
C. J. Boos, S. K. Soor, D. Kang, and G. Y.H. Lip
Relationship between circulating endothelial cells and the predicted risk of cardiovascular events in acute coronary syndromes
Eur. Heart J., May 1, 2007; 28(9): 1092 - 1101.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
I. Ben-Dor, M. Haim, E. Rechavia, D. Murninkas, D. Harell, A. Porter, Z. Iakobishvili, A. Battler, and D. Hasdai
Serum NT-proBNP Concentrations in the Early Phase Do Not Predict the Severity of Systolic or Diastolic Left Ventricular Dysfunction Among Patients With ST-Elevation Acute Myocardial Infarction
Angiology, January 1, 2007; 57(6): 686 - 693.
[Abstract] [PDF]


Home page
HeartHome page
G A Whalley, G D Gamble, and R N Doughty
Restrictive diastolic filling predicts death after acute myocardial infarction: systematic review and meta-analysis of prospective studies
Heart, November 1, 2006; 92(11): 1588 - 1594.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
B. Verges, M. Zeller, J. Desgres, G. Dentan, Y. Laurent, L. Janin-Manificat, I. L'Huillier, G. Rioufol, J.-C. Beer, H. Makki, et al.
High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock
Eur. Heart J., September 1, 2005; 26(17): 1734 - 1741.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. Prontera, S. Storti, M. Emdin, C. Passino, L. Zyw, G. C. Zucchelli, and A. Clerico
Comparison of a Fully Automated Immunoassay with a Point-of-Care Testing Method for B-Type Natriuretic Peptide
Clin. Chem., July 1, 2005; 51(7): 1274 - 1276.
[Full Text] [PDF]


Home page
Eur Heart JHome page
A. I. Larsen and K. Dickstein
BNP in acute coronary syndromes: the heart expresses its suffering
Eur. Heart J., August 1, 2004; 25(15): 1284 - 1286.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.